Read about our innovative clinical trial technologies.
Triall and Sphereon have won an R&D grant from the Dutch Government for implementing Self-Sovereign Identity technology in informed consent.
The Triall Newsletter provides a concise overview of product innovation updates, upcoming events, and anything else Triall-related.